CFTR corrector 8

CAS No. 1918142-35-4

CFTR corrector 8( —— )

Catalog No. M35744 CAS No. 1918142-35-4

CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 112 Get Quote
5MG 170 Get Quote
10MG 264 Get Quote
25MG 517 Get Quote
50MG 812 Get Quote
100MG 1305 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CFTR corrector 8
  • Note
    Research use only, not for human use.
  • Brief Description
    CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR).
  • Description
    CFTR corrector 8 is a potent CFTR modulator. CFTR can be used in the research of cystic fibrosis.
  • In Vitro
    CFTR corrector 8 (compound 12) shows EC50s of 1 μM (CSE-HRP assay) and 3 μM (HBE-TECC assay) .CFTR corrector 8 exhibits hepatocyte clearance rate of 1250/775 L/hr/kg (human/rat).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    CFTR
  • Recptor
    CFTR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1918142-35-4
  • Formula Weight
    539.52
  • Molecular Formula
    C29H27F2NO7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 110 mg/mL (203.88 mM; Ultrasonic )
  • SMILES
    COc1ccc2[C@H](C[C@H](Oc2c1)c1ccc(OC)c(OC)c1)NC(=O)C1(CC1)c1ccc2OC(F)(F)Oc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang X, et al. Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis. J Med Chem. 2018 Feb 22;61(4):1436-1449. ?
molnova catalog
related products
  • OSSK-630513

    A novel potent CFTR potentiator with Kd of 31.7 nM; potentially serves as lead compound for development of new drugs for the treatment of cystic fibrosis.

  • Nesolicaftor

    PTI-428 specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis.

  • Bamocaftor

    Bamocaftor is a CFTR channel (DeltaF508-CFTR mutation) corrector for CF transmembrane conductance regulators designed to restore F508del-CFTR protein function.